January 23, 2026
New Generics
Zylet® (loteprednol etabonate/tobramycin) – First-time generic
January 13, 2026 - Alembic launched an AB-rated generic version and B&L Americas launched an authorized brand alternative of Bausch Health’s Zylet (loteprednol etabonate/tobramycin) ophthalmic suspension.